Provided is a prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection. A prophylactic and/or therapeutic agent for Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A prophylactic and/or therapeutic agent for a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of Porphyromonas gingivalis infection, comprising killed Enterococcus faecalis. A medicine or food for prevention and/or treatment of a disease attributable to Porphyromonas gingivalis, comprising killed Enterococcus faecalis. A growth inhibitor for Porphyromonas gingivalis, comprising killed Enterococcus faecalis. An inhibitor for gingipain activity, comprising killed Enterococcus faecalis.
Provided is a viscous nutritional composition that can be used without effort two or three times per day by, for example, a patient undergoing rehabilitation or long-term treatment. This viscous nutritional composition contains nutrients that include proteins, lipids, and carbohydrates. The density (quantity of heat/g) of the viscous nutritional composition is 0.9–1.1 kcal/g, the quantity of heat per unit is 450–550 kcal/unit, and two or three units are to be used per person per day.
Provided is a liquid nutritional composition which is in a small volume, has high energy, and allows easy ingestion of a variety of nutrients such as protein, lipids, saccharides, dietary fiber, vitamins, minerals, and vitamin-like substances. Provided is a liquid nutritional composition which contains protein, fat, saccharides, and dietary fiber and has a calorie content of 1.7-2.3 kcal/mL, a viscosity at 25°C of 25-40 mPa·s, and an osmotic pressure of 420-500 mOsm/L, wherein: the composition contains 6.2-6.8 mass% of the protein, 6.4-7.0 mass% of lipids, 18-24 mass% of saccharides, and 1.5-2.5 mass% of dietary fiber; and the dietary fiber contains, in the total dietary fiber, 20-35 mass% of water-soluble dietary fiber, which has a weight average molecular weight of 15,000-25,000 and viscosity of a 5 mass% solution of 10 mPa·s or less.
Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.
A61L 2/18 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des substances chimiques des substances liquides
5.
AGENT FOR PREVENTION AND/OR TREATMENT OF PORPHYROMONAS GINGIVALIS INFECTION
Provided is an agent for the prevention and/or treatment of Porphyromonas gingivalis infection. An agent for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. An agent for the prevention and/or treatment of a disease caused by Porphyromonas gingivalis that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of a disease caused by of Porphyromonas gingivalis that contains killed Enterococcus faecalis. A Porphyromonas gingivalis growth inhibitor that contains killed Enterococcus faecalis. A gingipain activity inhibitor that contains killed Enterococcus faecalis.
Provided is an agent for the prevention and/or treatment of Porphyromonas gingivalis infection. An agent for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. An agent for the prevention and/or treatment of a disease caused by Porphyromonas gingivalis that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of Porphyromonas gingivalis infection that contains killed Enterococcus faecalis. A drug or a food for the prevention and/or treatment of a disease caused by of Porphyromonas gingivalis that contains killed Enterococcus faecalis. A Porphyromonas gingivalis growth inhibitor that contains killed Enterococcus faecalis. A gingipain activity inhibitor that contains killed Enterococcus faecalis.
Provided is a food material capable of preparing a mixer porridge-like food or a jelly thereof which is not subject to the formation of lumps (undissolved lumps of flour). Provided is granulated rice flour. The rice flour may be granulated together with a gelling agent and a starch degrading enzyme. A method for producing granulated rice flour includes spraying a liquid in which rice powder is dissolved to a mixture of rice powder, a gelling agent and a starch degrading enzyme. A food composition contains granulated rice flour. A mixer porridge-like food or a jelly thereof is obtained by dispersing granulated rice flour in a liquid.
In order to provide a nutritional composition that has a shape that is easy to administer or ingest, that does not exhibit a marked reduction in viscosity under acidity (when mixed with gastric juices), and that has excellent nutrients, the nutritional composition according to one embodiment of the present invention includes casein, collagen, and a thickener, where the thickener does not have a gelling property that is exhibited when cooled after heating, and is soluble in an acid.
A23L 29/238 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p. ex. gomme de caroube ou gomme de guar
A23L 29/256 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à base d'algues, p. ex. alginates, agar-agar ou carraghénane
A23L 29/269 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p. ex. xanthane ou dextrane
A23L 29/281 - Protéines, p. ex. gélatine ou collagène
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
A01N 63/20 - BactériesSubstances produites par des bactéries ou obtenues à partir de celles-ci
A01P 1/00 - DésinfectantsComposés antimicrobiens ou leurs mélanges
A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
A61L 15/36 - Bandages, pansements ou garnitures absorbant les fluides physiologiques tels que l'urine, le sang, p. ex. serviettes hygiéniques, tampons contenant des micro-organismes
Provided is a Clostridiodes difficile growth inhibitor. A Clostridiodes difficile growth inhibitor containing killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer, or a detergent for inhibiting growth of Clostridiodes difficile.
A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
A61K 8/97 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base d’algues, de champignons, de lichens ou de plantesCosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de leurs dérivés
A61L 15/36 - Bandages, pansements ou garnitures absorbant les fluides physiologiques tels que l'urine, le sang, p. ex. serviettes hygiéniques, tampons contenant des micro-organismes
The present invention provides a dextrin powder at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. A dextrin powder obtainable by spray drying a dextrin solution, wherein dextrin particles with a length to thickness ratio of 3 or more are contained in a proportion of 3% or more (as based on the number of the particles). A thickener comprising the dextrin powder. A food comprising the dextrin powder.
A23L 29/269 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p. ex. xanthane ou dextrane
A23F 3/14 - Préparations à base de thé, p. ex. utilisant des additifs
Provided is a novel preventive and/or therapeutic agent for Clostridium difficile infection. It has been discovered that bacteria belonging to the genus Enterococcus are capable of preventing and/or curing Clostridium difficile infection. Disclosed herein are: an agent that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus; a medicinal product that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus; and a food product that is for preventing and/or curing Clostridium difficile infection and that contains a bacterium belonging to the genus Enterococcus.
Provided, at a low cost, is a dextrin powder that can be used as a component for a thickener having good dispersibility in water or the like. This dextrin powder is obtained by spray-drying a dextrin solution, the powder containing 3% or more dextrin particles (count-based ratio of particles) with a ratio of length over thickness of 3 or greater. Also provided is a thickener containing the dextrin powder and a food product containing the dextrin powder.
A23F 3/16 - Extraction du théExtraits de théTraitement de l'extrait de théPréparation du thé instantané
A23L 29/30 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sirops d'hydrate de carboneAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sucresAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des alcools de sucre, p. ex. du xylitolAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des hydrolysats d'amidon, p. ex. de la dextrine
Provided, at a low cost, is a dextrin powder that can be used as a component for a thickener having good dispersibility in water or the like. This dextrin powder is obtained by spray-drying a dextrin solution, the powder containing 3% or more dextrin particles (count-based ratio of particles) with a ratio of length over thickness of 3 or greater. Also provided is a thickener containing the dextrin powder and a food product containing the dextrin powder.
A23L 29/30 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sirops d'hydrate de carboneAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sucresAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des alcools de sucre, p. ex. du xylitolAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des hydrolysats d'amidon, p. ex. de la dextrine
The present invention provides dextrin particles at a low cost which may be used as a component of thickeners that are good in dispersibility in moisture, etc. Fibrous dextrin particles. A thickener comprising the fibrous dextrin particles. A food comprising the fibrous dextrin particles. A method of preparing fibrous dextrin particles, comprising spray drying a dextrin solution with a viscosity of 100 mPa·s or more.
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
CA 03088601 2020-07-1534AbstractProvide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.Date Recue/Date Received 2020-07-15
Provided is a novel prophylactic and/or therapeutic agent for a pneumococcal infection. It is found that bacteria belonging to the genus enterococcus can prevent and/or treat a pneumococcal infection. Provided is a prophylactic and/or therapeutic agent for a pneumococcal infection, said agent containing bacteria belonging to the genus enterococcus. Provided is a prophylactic and/or therapeutic medicine for a pneumococcal infection, said medicine containing bacteria belonging to the genus enterococcus. Provided is a prophylactic and/or therapeutic food for a pneumococcal infection, said food containing bacteria belonging to the genus enterococcus.
Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus were found to be able to protect against MRSA infection. This MRSA infection protective agent contains bacteria belonging to the genus Enterococcus. Also provided are a medicine and a food, which are for protecting MRSA infection and contain bacteria belonging to the genus Enterococcus.
Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus were found to be able to protect against MRSA infection. This MRSA infection protective agent contains bacteria belonging to the genus Enterococcus. Also provided are a medicine and a food, which are for protecting MRSA infection and contain bacteria belonging to the genus Enterococcus.
Dextrin particles usable as a component of thickeners having satisfactory dispersibility in water, etc. are inexpensively provided. The present invention relates to: fibrous dextrin particles; a thickener comprising the fibrous dextrin particles; a food containing the fibrous dextrin particles; and a method for producing the fibrous dextrin particles which comprises spray-drying a dextrin solution having a viscosity of 100 mPa·s or higher.
A23L 29/206 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale
Dextrin particles usable as a component of thickeners having satisfactory dispersibility in water, etc. are inexpensively provided. The present invention relates to: fibrous dextrin particles; a thickener comprising the fibrous dextrin particles; a food containing the fibrous dextrin particles; and a method for producing the fibrous dextrin particles which comprises spray-drying a dextrin solution having a viscosity of 100 mPa∙s or higher.
A23L 29/206 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale
The present invention provides a gelling composition for preparing a gelatinous food which do not dissolve even when reheated (e.g., dysphagia diet).
The present invention provides a gelling composition for preparing a gelatinous food which retains its original shape even when reheated, wherein the gelling composition comprises a water-soluble polymer capable of forming a thermo-irreversible gel. Also provided is a method of gelling a food and enhancing the shape-retaining property of the food against reheating by using the above-described gelling composition, as well as a method of preparing a gelatinous food which retains its original shape even when reheated by using the above-described gelling composition.
A23L 29/20 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 29/212 - AmidonAmidon modifiéDérivés d'amidon, p. ex. esters ou éthers
A23L 29/256 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à base d'algues, p. ex. alginates, agar-agar ou carraghénane
A23L 29/269 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p. ex. xanthane ou dextrane
A23L 29/238 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p. ex. gomme de caroube ou gomme de guar
A23L 33/16 - Sels inorganiques, minéraux ou oligo-éléments
To provide a gelling composition for manufacturing a gelled foodstuff (e.g., deglutition adjustment food) that does not dissolve even when reheated. Provided is a gelling composition for manufacturing a gelled foodstuff that holds shape even when reheated after being manufactured, wherein the gelling composition contains a water-soluble polymer capable of forming a heat-irreversible gel. Also provided are a method for gelling a foodstuff and improving the ability of the foodstuff to retain shape in response to reheating after the foodstuff has been manufactured, and a method for manufacturing a gelled food item which holds shape even when reheated after being manufactured, using the gelling composition.
A23L 31/00 - Extraits ou préparations comestibles de champignonsLeur préparation ou leur traitement
A23L 29/20 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants
A23L 33/16 - Sels inorganiques, minéraux ou oligo-éléments
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements for humans containing nutrients of
vitamins, minerals, etc. made mainly from Coenzyme Q10,
alpha lipoic acid, chromium, etc. in the form of pill,
granulated powder, capsule, powder, block, liquid, jelly or
paste; dietetic food adapted for medical purposes, namely
foodstuffs in the form of powder made mainly from
polysaccharide thickener and dextrin to add thickness for
patients with swallowing disorders.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary supplements for humans; dietetic food adapted for
medical purposes, namely, foodstuffs in the form of powder
made mainly from polysaccharide thickener and dextrin to add
thickness for patients with swallowing disorders.
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
A23L 1/304 - Sels inorganiques, minéraux, oligo-éléments
A23L 1/09 - contenant des sirops d'hydrate de carbone; contenant des sucres; contenant des alcools de sucre, p.ex. xylitol; contenant des hydrolysats d'amidon, p.ex. dextrine (A23L 1/76, A23L 1/236 ont priorité);;
39.
Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
A61K 31/593 - Dérivés du 9,10-séco-cholestane, p. ex. cholécalciférol, vitamine D3
A61K 31/714 - Cobalamines, p. ex. cyanocobalamine, vitamine B12
A61K 33/04 - Soufre, sélénium ou tellureLeurs composés
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
A61K 47/46 - Ingrédients de constitution indéterminée ou leurs produits de réaction, p. ex. peau, os, lait, fibre de coton, coquille d’œuf, fiel de bœuf ou extraits de plante
A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
The present invention provides an enteral nutritional composition with which the labor of administering water between meals can be saved. The enteral nutritional composition comprises proteins, carbohydrates and lipids, with the calories per ml of the composition being less than 1 kcal and the moisture content being 30 percent by mass or more.
A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
A61K 35/60 - Poissons, p. ex. hippocampesŒufs de poisson
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
A61K 38/00 - Préparations médicinales contenant des peptides
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
Disclosed is an enteral nutritional composition which can save the effort of administrating dinking water between doses of the composition. The enteral nutritional composition comprises a protein, a carbohydrate and a lipid, has less than 1 kcal per mL, and has a water content of 30 mass% or more.
A61K 31/736 - Glucomannanes ou galactomannanes, p. ex. gomme de caroube, gomme de guar
A61K 35/60 - Poissons, p. ex. hippocampesŒufs de poisson
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
44.
COMPOSITION FOR REDUCING OXIDATIVE STRESS AND/OR SIDE EFFECTS OCCURRING DURING CANCER CHEMOTHERAPY OR IMPROVING NUTRITIONAL STATUS DURING CANCER CHEMOTHERAPY
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving a nutritional status during cancer chemotherapy. The composition is one for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant agent; (b) at least one component selected from the group consisting of vitamin B1, vitamin B, vitamin B6, niacin, and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12, and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.
Provided is a composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly. The composition is a composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly and comprises the following components (a) to (e): (a) an antioxidant: (b) at least one component selected from the group consisting of vitamin B1, vitamin B2, vitamin B6, niacin and pantothenic acid; (c) at least one component selected from the group consisting of folic acid and vitamin B12; (d) zinc; and (e) selenium.
COMPOSITION FOR IMPROVING NUTRITIONAL STATUS OF THE ELDERLY, REDUCING FREQUENCY OF FEVER OF THE ELDERLY AND/OR INCREASING IMMUNOCOMPETENCE OF THE ELDERLY
Provided is a composition for improving thenutritional status, reducing the frequency of fever,and/or increasing the immunocompetence of the elderly.The composition is one for improving the nutritionalstatus, reducing the frequency of fever, and/orincreasing the immunocompetence of the elderly andcomprises the following components (a) to (e): (a) anantioxidant agent; (b) at least one component selectedfrom the group consisting of vitamin B1, vitamin B2,vitamin B6, niacin, and pantothenic acid; (c) at leastone component selected from the group consisting of folicacid and vitamin B12; (d) zinc; and (e) selenium.
COMPOSITION FOR REDUCING OXIDATIVE STRESS AND/OR SIDE EFFECTS OCCURRING DURING CANCER CHEMOTHERAPY OR IMPROVING NUTRITIONAL STATUS DURING CANCER CHEMOTHERAPY
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy. The composition is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy and comprises the following components (a) to (f): (a) an antioxidant: (b) at least one component selected from the group consisting of vitamins B1, B2, B6, niacin and pantothenic acid; (c) at least one component selected from the group consisting of folic acid, vitamin B12 and vitamin A; (d) zinc; (e) selenium; and (f) coenzyme Q10.
Disclosed is a composition for reducing the level of glucose, a malondialdehyde-modified LDL, homocysteine and/or a C-reactive protein in the blood. Specifically disclosed is a composition for reducing the level of at least one substance selected from the group consisting of glucose, a malondialdehyde-modified LDL, homocysteine and a C-reactive protein in the blood, which comprises the following components (a) and (b): (a) at least one component selected from the group consisting of vitamin B12, vitamin B6 and folic acid; and (b) at least one component selected from the group consisting of zinc, selenium and an anti-oxidant vitamin.
A61K 31/714 - Cobalamines, p. ex. cyanocobalamine, vitamine B12
A61K 31/07 - Composés du rétinol, p. ex. vitamine A
A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
